Difference between revisions of "Part:BBa K817000"
(→IISER_Bhopal 2020) |
|||
(6 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K817000 short</partinfo> | <partinfo>BBa_K817000 short</partinfo> | ||
Line 5: | Line 4: | ||
This is the GLP-1 coding part along with the signal peptide sequence. | This is the GLP-1 coding part along with the signal peptide sequence. | ||
− | + | ===Method=== | |
− | === | + | To check whether our bacteria successfully secrete GLP-1 to the environment, we collected the bacterial media and measure its GLP-1 concentration. After centrifugation of bacterial culture, we collected the supernatant and passed it through 0.22 μm filter to exclude bacteria. Since the secreted GLP-1 is too diluted by the large volume of media, we concentrated the solution by 5 kDa ultra centrifugal filter tubes. We also collected the bacterial pellet and add lyze it by ''E. coli'' lysis buffer and freeze-thaw to measure GLP-1 inside bacteria. Both Immunoblotting and ELISA are used to detect GLP-1 concentration inside and outside bacteria. |
+ | |||
+ | ===Protocol=== | ||
+ | ====A. Sample Preparation==== | ||
+ | #310 μL Bacterial culture was cultured in 5mL LB at 37℃, with suitable concentration of antibiotics shaking till 600 nm absorbance in cuvette is 1.5 (usually it takes about 18 hr). | ||
+ | #Centrifuge the bacterial culture at 12000 rpm for 3 min. | ||
+ | #Pass the supernatant through 0.22 μm filter. Transfer the supernatant to 5 kDa ultra centrifugal filter tubes and centrifuge at 10000 rpm for 40 min. | ||
+ | #Add 250 μL of ''E. coli'' lysis buffer to the pellet and use liquid Nitrogen to freeze-thaw for three cycles. | ||
+ | #Heat the samples at 95。C for 10 min before immune-blotting. | ||
+ | |||
+ | ====B. Dot-Blotting==== | ||
+ | #Soak the PVDF membrane in ethanol for 5 min to activate the membrane. | ||
+ | #Drop every 2 μL sample in a very small area on the membrane. | ||
+ | #Blocking with 5% de-fat milk (in PBST) for 1 hr. | ||
+ | #Wash with PBST for 10 min, repeat 3 times. | ||
+ | #Add primary antibody (1:1000 dilution in PBST) and incubate at 4℃ overnight. | ||
+ | #Wash with PBST for 10 min, repeat 3 times. | ||
+ | #Add secondary antibody (1:5000 dilution in PBST) and incubate at 25℃ 2 hr. | ||
+ | #Wash with PBST for 10 min, repeat 3 times. | ||
+ | #Mix 2 mL ECL with 2mL substrate, add to the membrane and let stand for 5 min. | ||
+ | #Expose the membrane to the film in dark room. | ||
+ | |||
+ | |||
+ | ====C. ELISA==== | ||
+ | #Wash the wells with 250 μL Wash Buffer. | ||
+ | #Add 100 μL Assay Buffer to each well, and add 100 μL standards in ascending orders to wells, and add samples in the remaining wells. | ||
+ | #Incubate at 4℃ overnight. | ||
+ | #Decant liquid from plate. | ||
+ | #Wash 5 times with 250 μL Wash Buffer. | ||
+ | #Add 200 μL Detection Conjugate in each well. Incubate 2 hr at room temperature. | ||
+ | #Wash 3 times with 250 μL Wash Buffer. | ||
+ | #Add 200 μL diluted substrate and incubate for 20 min. | ||
+ | #Read plate on fluorescence plate reader with excitation/emission wavelength of 355 nm/460 nm. | ||
+ | |||
+ | |||
+ | ===Data=== | ||
+ | ====A. Dot-Blotting==== | ||
+ | |||
+ | <center><html><img src='https://static.igem.org/mediawiki/2012/6/60/NTU-Taida-Result-GLP-fig1.png' width='250px'></html></center> | ||
+ | |||
+ | The upper dot is from the lyzed bacterial pellet, which represents the GLP-1 inside the bacteria. The middle part is from bacterial culture supernatant, which means the secreted GLP-1, and the left dot is the media we did 10X concentration, the right dot is the one we did 100X concentration. The lower dot is from pure GLP-1 solution as positive control. | ||
+ | |||
+ | ====B. ELISA==== | ||
+ | |||
+ | <center><html><img src='https://static.igem.org/mediawiki/2012/0/0e/NTU-Taida-Result-GLP-fig2.png' width='450px'></html></center> | ||
+ | |||
+ | The left bar is from the lyzed bacterial pellet, which represents the GLP-1 inside the bacteria. The right bar is from 10X concentrated bacterial culture supernatant, which means the secreted GLP-1. | ||
+ | |||
+ | ===Conclusion=== | ||
+ | Our data indicates that although there is much GLP-1 inside the bacteria, some of GLP-1 is secreted by our signal peptide design. The secreted GLP-1 can be delivered to intestinal lumen and carry out its physiological function once absorbed. | ||
+ | |||
+ | =IISER_Bhopal 2020= | ||
+ | (Author: Priya Sharma) | ||
+ | |||
+ | ===Part Information=== | ||
+ | Glucagon-like peptide-1 (GLP-1) is a peptide hormone and is derived from proglucagon. It is an incretin molecule therefore, it can decrease the blood sugar levels in a glucose-dependent manner by stimulating the secretion of insulin. | ||
+ | GLP-1 (7–36 amide), was isolated from the gut. It has a half-life of about 1-2 minutes in humans as it is degraded by dipeptidyl peptidase 4 (DPP4). DPP-4 inhibitors are used in type-2 diabetes management as they protect GLP-1 from degradation and are used as therapeutics for type-2 diabetes management. Many GLP-1 analogues are used by type-2 diabetes patients as they are resistant to DPP-4 and have considerably longer half-lives. | ||
+ | |||
+ | 3D model- https://swissmodel.expasy.org/interactive/FKgTke/models/ | ||
+ | |||
+ | ===References=== | ||
+ | 1. Holst JJ. From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy. Front Endocrinol (Lausanne). 2019;10:260. Published 2019 Apr 26. doi:10.3389/fendo.2019.00260 | ||
<!-- --> | <!-- --> |
Latest revision as of 12:36, 26 October 2020
SP1-GLP1
This is the GLP-1 coding part along with the signal peptide sequence.
Method
To check whether our bacteria successfully secrete GLP-1 to the environment, we collected the bacterial media and measure its GLP-1 concentration. After centrifugation of bacterial culture, we collected the supernatant and passed it through 0.22 μm filter to exclude bacteria. Since the secreted GLP-1 is too diluted by the large volume of media, we concentrated the solution by 5 kDa ultra centrifugal filter tubes. We also collected the bacterial pellet and add lyze it by E. coli lysis buffer and freeze-thaw to measure GLP-1 inside bacteria. Both Immunoblotting and ELISA are used to detect GLP-1 concentration inside and outside bacteria.
Protocol
A. Sample Preparation
- 310 μL Bacterial culture was cultured in 5mL LB at 37℃, with suitable concentration of antibiotics shaking till 600 nm absorbance in cuvette is 1.5 (usually it takes about 18 hr).
- Centrifuge the bacterial culture at 12000 rpm for 3 min.
- Pass the supernatant through 0.22 μm filter. Transfer the supernatant to 5 kDa ultra centrifugal filter tubes and centrifuge at 10000 rpm for 40 min.
- Add 250 μL of E. coli lysis buffer to the pellet and use liquid Nitrogen to freeze-thaw for three cycles.
- Heat the samples at 95。C for 10 min before immune-blotting.
B. Dot-Blotting
- Soak the PVDF membrane in ethanol for 5 min to activate the membrane.
- Drop every 2 μL sample in a very small area on the membrane.
- Blocking with 5% de-fat milk (in PBST) for 1 hr.
- Wash with PBST for 10 min, repeat 3 times.
- Add primary antibody (1:1000 dilution in PBST) and incubate at 4℃ overnight.
- Wash with PBST for 10 min, repeat 3 times.
- Add secondary antibody (1:5000 dilution in PBST) and incubate at 25℃ 2 hr.
- Wash with PBST for 10 min, repeat 3 times.
- Mix 2 mL ECL with 2mL substrate, add to the membrane and let stand for 5 min.
- Expose the membrane to the film in dark room.
C. ELISA
- Wash the wells with 250 μL Wash Buffer.
- Add 100 μL Assay Buffer to each well, and add 100 μL standards in ascending orders to wells, and add samples in the remaining wells.
- Incubate at 4℃ overnight.
- Decant liquid from plate.
- Wash 5 times with 250 μL Wash Buffer.
- Add 200 μL Detection Conjugate in each well. Incubate 2 hr at room temperature.
- Wash 3 times with 250 μL Wash Buffer.
- Add 200 μL diluted substrate and incubate for 20 min.
- Read plate on fluorescence plate reader with excitation/emission wavelength of 355 nm/460 nm.
Data
A. Dot-Blotting
The upper dot is from the lyzed bacterial pellet, which represents the GLP-1 inside the bacteria. The middle part is from bacterial culture supernatant, which means the secreted GLP-1, and the left dot is the media we did 10X concentration, the right dot is the one we did 100X concentration. The lower dot is from pure GLP-1 solution as positive control.
B. ELISA
The left bar is from the lyzed bacterial pellet, which represents the GLP-1 inside the bacteria. The right bar is from 10X concentrated bacterial culture supernatant, which means the secreted GLP-1.
Conclusion
Our data indicates that although there is much GLP-1 inside the bacteria, some of GLP-1 is secreted by our signal peptide design. The secreted GLP-1 can be delivered to intestinal lumen and carry out its physiological function once absorbed.
IISER_Bhopal 2020
(Author: Priya Sharma)
Part Information
Glucagon-like peptide-1 (GLP-1) is a peptide hormone and is derived from proglucagon. It is an incretin molecule therefore, it can decrease the blood sugar levels in a glucose-dependent manner by stimulating the secretion of insulin. GLP-1 (7–36 amide), was isolated from the gut. It has a half-life of about 1-2 minutes in humans as it is degraded by dipeptidyl peptidase 4 (DPP4). DPP-4 inhibitors are used in type-2 diabetes management as they protect GLP-1 from degradation and are used as therapeutics for type-2 diabetes management. Many GLP-1 analogues are used by type-2 diabetes patients as they are resistant to DPP-4 and have considerably longer half-lives.
3D model- https://swissmodel.expasy.org/interactive/FKgTke/models/
References
1. Holst JJ. From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy. Front Endocrinol (Lausanne). 2019;10:260. Published 2019 Apr 26. doi:10.3389/fendo.2019.00260
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]